跳至主要内容
临床试验/NCT03761381
NCT03761381招募中不适用

Using Optical Coherence Tomography and Noninvasive Retinal Amyloid Imaging to Capture Retinal Changes Associated With Dementia

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Retinal amyloid protein detection

研究概览

简要总结

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to:

  1. Detect retinal blood vessel and blood flow changes in participants with dementia.
  2. Detect amyloid protein deposits in the retinas of participants with dementia.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Retinal amyloid protein detection

时间窗: 1 day

OCT and OCT angiography will be used to detect levels of amyloid proteins deposits within the retina layers on the single enrollment visit only. An increase in the protein detection is expected in the dementia group.

次要结局

  • Decreased blood flow(1 day)
  • Decreased retinal perfusion(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Huang

David Huang, MD, PhD, Peterson Professor of Ophthalmology and Professor orf Biomedical Engineering

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验